Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) — Analysis Summary
Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) has a market cap of $208.34M with year-over-year revenue growth of -46.1%. Net margin stands at -80.2%. The stock trades at a P/E ratio of -2.6.
Key Takeaways
- Revenue changed -46.1% year-over-year
- Net margin of -80.2%
- P/E ratio of -2.6
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, ARCT posted revenue growth of -46.1% and trades at a P/E of -2.6.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.